Skip to main content

Table 3 Characteristics of treatment and follow up. All data presented as count (percent), unless otherwise specified

From: A retrospective study on incidence, diagnosis, and clinical outcome of gastric-type endocervical adenocarcinoma in a single institution

 

GAS

N = 5

UEA

N = 19

P-Value

Treatment

 Radical Hysterectomy

4 (80.0)

12 (63.2)

0.63

 Chemotherapy

2 (40.0)

3 (15.8)

0.27

 Radiation Therapy

3 (60.0)

5 (26.3)

0.29

 Pelvic Exenteration

1 (20.0)

0 (0.0)

0.21

 LEEP

0 (0.0)

9 (47.4)

0.19

 Cervical Biopsy

0 (0.0)

2 (10.5)

0.99

Recurrence

 Yes

3 (60.0)

7 (36.8)

0.61

 Not Observed

2 (40.0)

12 (63.2)

Death

 Yes

3 (60.0)

6 (31.6)

0.33

 Not Observed

2 (40.0)

13 (68.4)

Time to Death (months)

 Median (95% CI)

22.0 (15.6, 28.4)

118.0 (59.4, 176.6)

0.043a

  1. a – Test of equality of survival distributions using the Kaplan-Meier Estimator and Log Rank test